Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis.
Ping L ZhangBrandon D MetcalfSarang KhanJamal AbukhaledKhalid ZafarWei LiHassan D Kanaan
Published in: Ultrastructural pathology (2024)
The hydralazine-induced autoimmune phenomenon can be seen in IgM-dominant ICMGN, which should be classified as a subtype of membranoproliferative glomerulonephritis.